NCT01180465
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2010
Completion: Sep 30, 2010